BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30669145)

  • 21. Primary Central Nervous System Lymphoma Complicated by Cerebral Venous Sinus Thrombosis: A Case Report.
    Medeiros T; Sequeira S; Mendes M; Hierro F; Duarte S
    Eur J Case Rep Intern Med; 2023; 10(8):003994. PubMed ID: 37554475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse Large B-Cell Lymphoma in Bilateral Basal Ganglia: A Rare Case Report.
    Da Silva AJ; Castro Pinheiro Gomes FE; Barros Pimentel Tenório GM; Pinto Almeida LM
    Cureus; 2022 Dec; 14(12):e32743. PubMed ID: 36561327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vanishing Brain Lesions in a Patient with Vision Loss and Ataxia: A Case of CNS Lymphoma with Corticosteroid Related Regression.
    Elavarasi A; Rao S; Ramakrishnan S; Bhatt D
    Ann Indian Acad Neurol; 2022; 25(3):536-540. PubMed ID: 35936585
    [No Abstract]   [Full Text] [Related]  

  • 24. Seizures in steroid-responsive encephalopathy.
    Xu X; Lin A; Wang X
    Neurol Sci; 2021 Feb; 42(2):521-530. PubMed ID: 33219869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of paediatric primary central nervous system lymphoma treated with high-dose methotrexate and rituximab-based chemoimmunotherapy and whole brain radiotherapy followed by tumour bed boost with three-dimensional conformal radiation technique.
    Adhikari N; Biswas A; Bakhshi S; Khanna G; Suri V
    Childs Nerv Syst; 2018 Sep; 34(9):1777-1783. PubMed ID: 29744624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
    Morris PG; Correa DD; Yahalom J; Raizer JJ; Schiff D; Grant B; Grimm S; Lai RK; Reiner AS; Panageas K; Karimi S; Curry R; Shah G; Abrey LE; DeAngelis LM; Omuro A
    J Clin Oncol; 2013 Nov; 31(31):3971-9. PubMed ID: 24101038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
    Hattori K; Sakata-Yanagimoto M; Okoshi Y; Kato T; Kurita N; Yokoyama Y; Obara N; Takano S; Ishikawa E; Yamamoto T; Matsumura A; Hasegawa Y; Chiba S
    J Clin Exp Hematop; 2017 Oct; 57(2):41-46. PubMed ID: 28781291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
    Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
    Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
    Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
    Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of primary central nervous system lymphoma.
    Royer-Perron L; Hoang-Xuan K
    Presse Med; 2018; 47(11-12 Pt 2):e213-e244. PubMed ID: 30416008
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.